<p><strong>mRNA Therapeutics CDMO Market</strong> Size, Share, Trends, Scope, Statistics, <strong>By Application</strong>&nbsp;(C Viral Vaccines, Protein Replacement Therapies, Cancer Immunotherapies),&nbsp;<strong>By Indication</strong>&nbsp;(Infectious Diseases, Metabolic &amp; Genetic Diseases, Cardiovascular &amp; Cerebrovascular Diseases),&nbsp;<strong>By End-use</strong>&nbsp;(Biotech Companies, Pharmaceutical Companies, Government &amp; Academic Research Institutes),&nbsp;<strong>By Region</strong>&nbsp;(North America, Europe, Asia Pacific, Latin America, Middle East and Africa), Industry Forecast <strong>(2025-2032)</strong></p>

mRNA Therapeutics CDMO Market Size to Hit USD 10.72 Billion by 2032